Peapack Gladstone Financial Corp / BMY
Peapack Gladstone Financial Corp’s Bristol-Myers Squibb Co Position
Does Peapack Gladstone Financial Corp own Bristol-Myers Squibb Co (BMY)? Yes — 439.5K shares worth $27M (+0.34% of its 13F portfolio) as of Q1 2026, down from 449.9K shares the prior filed quarter.
Position Value
$27M
Q1 2026
Shares
439.5K
% of Portfolio
+0.34%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 439.5K | $27M | +0.34% |
| Q4 2025 | 449.9K | $24M | +0.31% |
| Q3 2025 | 477.6K | $22M | +0.28% |
| Q2 2025 | 458.6K | $21M | +0.30% |
| Q1 2025 | 479.3K | $29M | +0.43% |
| Q4 2024 | 484.6K | $27M | +0.40% |
| Q3 2024 | 493.0K | $26M | +0.37% |
| Q2 2024 | 563.3K | $23M | +0.36% |
| Q1 2024 | 578.8K | $31M | +0.49% |
| Q4 2023 | 602.1K | $31M | +0.52% |
| Q3 2023 | 634.1K | $37M | +0.68% |
| Q2 2023 | 637.7K | $41M | +0.73% |
| Q1 2023 | 647.6K | $45M | +0.86% |
| Q4 2022 | 644.4K | $46M | +0.91% |
| Q3 2022 | 633.7K | $45M | +0.92% |
| Q2 2022 | 596.2K | $46M | +1.05% |
| Q1 2022 | 582.0K | $43M | +0.83% |
| Q4 2021 | 576.1K | $36M | +0.68% |
| Q3 2021 | 575.2K | $34M | +0.70% |
| Q2 2021 | 542.1K | $36M | +0.87% |
| Q1 2021 | 550.1K | $35M | +0.90% |
| Q4 2020 | 558.1K | $35M | +1.04% |
| Q3 2020 | 554.6K | $33M | +1.21% |
| Q2 2020 | 565.1K | $33M | +1.32% |
| Q1 2020 | 548.2K | $31M | +1.44% |
| Q4 2019 | 512.4K | $33M | +1.32% |
| Q3 2019 | 424.8K | $22M | +0.93% |
| Q2 2019 | 427.4K | $19M | +0.84% |
| Q1 2019 | 384.7K | $18M | +0.83% |
| Q4 2018 | 341.5K | $18M | +0.91% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Peapack Gladstone Financial Corp’s full portfolio or all institutional holders of BMY.